BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2882992)

  • 1. Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in man.
    Wedlund PJ; Sweetman BJ; Wilkinson GR; Branch RA
    Drug Metab Dispos; 1987; 15(2):277-9. PubMed ID: 2882992
    [No Abstract]   [Full Text] [Related]  

  • 2. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
    Küpfer A; Brilis GM; Watson JT; Harris TM
    Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism.
    Wedlund PJ; Aslanian WS; McAllister CB; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1984 Dec; 36(6):773-80. PubMed ID: 6499356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.
    Küpfer A; Branch RA
    Clin Pharmacol Ther; 1985 Oct; 38(4):414-8. PubMed ID: 4042524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family studies of mephenytoin hydroxylation deficiency.
    Inaba T; Jurima M; Kalow W
    Am J Hum Genet; 1986 May; 38(5):768-72. PubMed ID: 3717162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.
    Küpfer A; Preisig R
    Eur J Clin Pharmacol; 1984; 26(6):753-9. PubMed ID: 6489416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective metabolism of mephenytoin in man.
    Küpfer A; Roberts RK; Schenker S; Branch RA
    J Pharmacol Exp Ther; 1981 Jul; 218(1):193-9. PubMed ID: 7241378
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of mephenytoin and 4'-hydroxymephenytoin in urine by high performance liquid chromatography].
    Ruan ZR; Cheng YS; Ding DY
    Yao Xue Xue Bao; 1994; 29(8):624-8. PubMed ID: 7985520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-mephenytoin hydroxylation phenotypes in a Jordanian population.
    Hadidi HF; Irshaid YM; Woosley RL; Idle JR; Flockhart DA
    Clin Pharmacol Ther; 1995 Nov; 58(5):542-7. PubMed ID: 7586948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of mephenytoin, 4-hydroxymephenytoin and 4-hydroxyphenytoin enantiomers in human urine by cyclodextrin micellar electrokinetic capillary chromatography: simple determination of a hydroxylation polymorphism in man.
    Desiderio C; Fanali S; Küpfer A; Thormann W
    Electrophoresis; 1994 Jan; 15(1):87-93. PubMed ID: 8143685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative metabolism of hexobarbital in human liver: relationship to polymorphic S-mephenytoin 4-hydroxylation.
    Knodell RG; Dubey RK; Wilkinson GR; Guengerich FP
    J Pharmacol Exp Ther; 1988 Jun; 245(3):845-9. PubMed ID: 3385644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mephenytoin hydroxylation polymorphism: characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo.
    Meier UT; Dayer P; Malè PJ; Kronbach T; Meyer UA
    Clin Pharmacol Ther; 1985 Nov; 38(5):488-94. PubMed ID: 4053486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotyping polymorphic drug metabolism in the French Caucasian population.
    Jacqz E; Dulac H; Mathieu H
    Eur J Clin Pharmacol; 1988; 35(2):167-71. PubMed ID: 3191936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
    Maguire JH; Butler TC; Dudley KH
    Drug Metab Dispos; 1982; 10(6):595-8. PubMed ID: 6130906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased systemic availability of drugs during acute ethanol intoxication: studies with mephenytoin in the dog.
    Zysset T; Preisig R; Bircher J
    J Pharmacol Exp Ther; 1980 Apr; 213(1):173-8. PubMed ID: 7188964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic differences in mephenytoin pharmacokinetics in normal subjects.
    Wedlund PJ; Aslanian WS; Jacqz E; McAllister CB; Branch RA; Wilkinson GR
    J Pharmacol Exp Ther; 1985 Sep; 234(3):662-9. PubMed ID: 4032286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians.
    Jurima M; Inaba T; Kadar D; Kalow W
    Br J Clin Pharmacol; 1985 Apr; 19(4):483-7. PubMed ID: 3994895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselectivity of the arene epoxide pathway of mephenytoin hydroxylation in man.
    Küpfer A; Lawson J; Branch RA
    Epilepsia; 1984 Feb; 25(1):1-7. PubMed ID: 6420144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of hydroxylated and demethylated metabolites of mephenytoin in man and laboratory animals using gas-liquid chromatography and high-performance liquid chromatography.
    Küpfer A; James R; Carr K; Branch R
    J Chromatogr; 1982 Oct; 232(1):93-100. PubMed ID: 7142342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mephenytoin and sparteine pharmacogenetics in Canadian Caucasians.
    Inaba T; Jurima M; Nakano M; Kalow W
    Clin Pharmacol Ther; 1984 Nov; 36(5):670-6. PubMed ID: 6488688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.